IL-8, a proinflammatory chemokine, inhibits anti-tumor immune responses by inducing MDSCs in the tumor microenvironment and expanding the desmoplastic tumor stroma, similar to IL-6 (Alfaro et al., 2016). The gene discussed is CXCL8; the disease is neoplasm.